Immunological biomarkers associated with brain structure and executive function in late‐life depression: exploratory pilot study
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Objective: Several immunological biomarkers are altered in late‐life major depressive disorder (LLD). Immunological alterations could contribute to LLD's consequences, but little is known about the relations between specific immunological biomarkers and brain health in LLD. We performed an exploratory pilot study to identify, from several candidates, the specific immunological biomarkers related to important aspects of brain health that are altered in LLD (brain structure and executive function). Methods: Adults (n = 31) were at least 60 years old and had major depressive disorder. A multiplex immunoassay assessed 13 immunological biomarkers, and we examined their associations with structural MRI (grey matter volume and white matter hyperintensity volume (WMH)) and executive function (Color–Word Interference and Trail‐Making tests) measures. Results: Vascular endothelial growth factor (VEGF) and the chemokine eotaxin had significant negative associations with grey matter volume (VEGF:n = 31,r = −0.65; eotaxin:n = 29,r = −0.44). Tumor necrosis factor alpha (TNF‐α) had a significant positive relationship with WMHs (n = 30,r = 0.52); interferon‐γ (IFN‐γ) and macrophage inflammatory protein‐1α (MIP‐1α) were also significantly associated with WMHs (IFN‐γ:n = 31,r = 0.48; MIP‐1α:n = 29,r = 0.45). Only eotaxin was associated with executive function (set‐shifting performance as measured with the Trail‐making test:n = 33,r = −0.43). Conclusions: Immunological markers are associated with brain structure in LLD. We found the immunological correlates of grey and white matter differ. Prospective studies are needed to evaluate whether these immunological correlates of brain health increase the risk of LLD's consequences. Eotaxin, which correlated with both grey matter volume and set‐shifting performance, may be particularly relevant to neurodegeneration and cognition in LLD. Copyright © 2016 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
'Vascular Depression' Hypothesis
Alexopoulos, G. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220033006 · Cited by 1,843 · cited 2×
“contributor to LLD’s consequences (Alexopoulos et al., 1997); for example, evidence shows that LLD patients with a greater burden of cerebrovascular disease (measured by white matter hyperintensities volume (WMH)) are at increased risk for dementia (Steffens et al.”
BackgroundThe ageing systemic milieu negatively regulates neurogenesis and cognitive function
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 2×
“…these pro-inflammatory pathways may be useful to prevent or attenuate the progression of white matter pathology, and may represent a mechanism by which TNF-α antagonism has an antidepressant effect in some patients (Raison et al., 2013) (i.e. by attenuating white matter disease progression).”
BackgroundVEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296 · cited 1×
“VEGF increases the permeability of the blood brain barrier (Zhang et al., 2000) and might relate to grey matter volume by increasing the brain’s exposure to neurotoxic factors.”
BackgroundLiu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
The vascular depression hypothesis: mechanisms linking vascular disease with depression
Taylor, W. D., Aizenstein, H. J., & Alexopoulos, G. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.20 · Cited by 923
Self-citationA detailed examination of cytokine abnormalities in Major Depressive Disorder
Simon, N. M., McNamara, K., Chow, C. W., Maser, R. S., Papakostas, G. I., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K. K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.004 · Cited by 286 · cited 3×
“…in addition to proinflammatory cytokines, a range of other immunological markers, including chemokines, may be altered in depression (e.g. see Simon et al. (2008); GrassiOliveira et al. (2012); Carvalho et al. (2015); Lehto et al. (2010); Magalhaes et al. (2014) and for reviews/meta-analyses…”
BackgroundHiles, S. A., Baker, A. L., de Malmanche, T., & Attia, J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.001 · Cited by 274
Cited by
Mechanisms and treatment of late-life depression
Alexopoulos, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0514-6 · Cited by 592
How inflammation affects the brain in depression: a review of functional and structural MRI studies
Han, K.-M., & Ham, B.-J. (2021) · Journal of Clinical Neurology · doi:10.3988/jcn.2021.17.4.503 · Cited by 187
Lee, E. E., Hong, S., Martin, A. S., Eyler, L. T., & Jeste, D. V. (2017) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.09.009 · Cited by 94
Peripheral Inflammatory Parameters in Late-Life Depression: A Systematic Review
Martínez-Cengotitabengoa, M., Carrascón, L., O’Brien, J., Díaz-Gutiérrez, M.-J., Bermúdez-Ampudia, C., Sanada, K., Arrasate, M., & González-Pinto, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122022 · Cited by 85
Druzhkova, T., Pochigaeva, K., Yakovlev, A., Kazimirova, E., Grishkina, M., Chepelev, A., Guekht, A., & Gulyaeva, N. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-018-0367-3 · Cited by 37
Metadata
- Authors
- Smagula, S. F., Lotrich, F. E., Aizenstein, H. J., Diniz, B. S., Krystek, J., Wu, G. F., Mulsant, B. H., Butters, M. A., Reynolds, C. F., & Lenze, E. J.
- Venue
- International Journal of Geriatric Psychiatry
- Publisher
- Wiley
- Published
- 2016-06-10
- Volume
- 32
- Issue
- 6
- Pages
- 692-699
- ISSN
- 0885-6230 (ISSN-L)
- 1099-1166
- OpenAlex
- W2408809560
- Cited by
- 41
- References
- 16
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunological biomarkers associated with brain structure and executive function in late‐life depression: exploratory pilot study. https://app.cochat.ai/papers/10.1002/gps.4512
- The paper
- Smagula, S. F., Lotrich, F. E., Aizenstein, H. J., Diniz, B. S., Krystek, J., Wu, G. F., Mulsant, B. H., Butters, M. A., Reynolds, C. F., & Lenze, E. J. (2017). Immunological biomarkers associated with brain structure and executive function in late‐life depression: exploratory pilot study. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.4512
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.